Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study
International Immunopharmacology(2022)
Key words
Combination therapy,Immunotherapy,Refractory hepatocellular carcinoma,Second-line treatment,NLR PLR
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined